The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has entered a key licensing agreement with Telesis Bio Inc. to integrate the ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

The Brazil Veterinary Medicine Market, valued at USD 2.65 Billion in 2024, is projected to reach USD 4.15 Billion by 2030, ...

Hyderabad: Aurobindo Pharma has announced that Curateq Biologics Private Limited, a wholly owned subsidiary of the Company, ...

Peter DeYoung, CEO at Piramal Pharma Limited, explains how Piramal is meeting the growing demand for integrated biologics ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

No. of COVID-19 Cases Hikes, Triggering Speculation in Related Pharma; CSPC PHARMA/ JUNSHI BIO/ SIMCERE PHARMA/ BRII-B Surge ...

With a better upfront offer on the table, enough bluebird bio investors have tendered their shares for the company's sale to ...

The concerns of industry experts expressed at INTERPHEX in April 2025 are still pertinent in an uncertain global political ...

The Temperature Controlled Pharma Packaging Market is poised for substantial growth, driven by rising global demand f ...